HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical Implications

Conclusion: The HIV drug efavirenz inhibits CYP21A2 activity in vitro through direct interaction with enzyme catalysis at therapeutic concentrations. This may have clinical implications for HIV treatment in children and adults. However, so far, clinical data are scarce, and further studies are needed to be able to draw clinical conclusions.Horm Res Paediatr
Source: Hormone Research in Paediatrics - Category: Endocrinology Source Type: research